1) Inability to perform assessment of blood flow using ultrasound Doppler (due to cost)
ciii 2) Inability to do nerve conduction studies 3) Inability to do C-peptide (due to cost)
civ
REFERENCES
1. WHO Consultation Group. Definition, diagnosis and classification of Diabetes Mellitus and its complications. Part I: Diagnosis and classification of diabetes mellitus.
World Health Organization. Department of Non-communicable Disease Surveillance.
Geneva: World Health Organization 1999.
2. American Diabetes Association (ADA). Report of the Expert Committee on the
Diagnosis and Classification of Diabetes Mellitus. Diabetes care: 26 suppl 1; 2003: S5 – S12.
3. WHO Press Release. Global Burden of Diabetes. Press Release WHO/63. 1998 Sep
14.
4. WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of
diabetes and impaired glucose tolerance in adults. Diabetes care 1993: 16: 157 – 177.
5. International Diabetes Federation. Diabetes Atlas, 2nd Edition. Brussels, 2003.
(Accessed online, August 2007).
6. Williams RH, Larsen PR, Kronenberg HM, et al. Williams Textbook of
Endocrinology WB Sunders. 10th Edition. 2003. Pg 1427.
7. Longmore M, Wilkinson I.B, Davidson EH, Foulkes A, Mafi AR. Endocrinology. In:
Longmore M, Wilkinson IB, Davidson EH, Foulkes A, Mafi AR (eds). Oxford Handbook of Clinical Medicine 8thedn. New York. Oxford University Press. 2010.P198.
8. Scott D. Ramsey,Katherine Newton, David Blough, et al. Clinical
Care/Education/Nutrition: Incidence, outcomes, and cost of foot ulcers in patients with diabetes.
9. Rhys W., Mark A. Size of the problem: Epidemiological and economic aspects of
foot problems in Diabetes. In: Boultom AJM; Connor H; Cavanagh P.R (Eds), The foot in diabetes. 3rd edition. John Wiley and Sons Ltd: 2000:19-31.
10. Morbach S, Lutale J, Wivwanathan V, et al. Regional differences in risk factors and
clinical presentation of diabetic foot lesions. DiabetMed 2004; 21: 91 – 95.
11. Solagberu BA. Diabetic foot in Nigeria – a review article. Afr J Med Sci 2003. 32,
111 – 118.
12. Boulton AJM, Vileikyte L. Diabetic foot problems and their management around
the world. In: Bowker JH, Pfeiffer MA, eds. Levin & O’Neal’s “The Diabetic foot”. 6th ed.
St. Louis: MO; Mosby, 2000; 261 – 272.
13. Nathan DM. Long term complications of Diabetes mellitus. N Engl J Med 1993;
328: 1676 – 9.
cv
14. International Working Group on the Diabetic Foot. International Consensus on the
Diabetic foot & practical Guidelines on the Management and prevention of the Diabetic foot. In: Introduction. Amsterdam, 2007.
15. Boulton AJM. The Diabetic foot: a major problem for the new millennium. Intdiab
monitor 2001; 13:1; 1 -7.
16. Gulam – Abbas Z, Lutale JK, Morbach S, Archibald LK. Clinical outcome of diabetes
patients hospitalized with foot ulcers, Dar es Salaam, Tanzania. Diabet Med 2002: 19:
575 – 579.
17. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and foot care;
Time to Act in :chapter 2, scope of the problem. Pg 22-27.A joint publication of the IDF and the IWGDF.Brussels 2005.
18. Ekere AU, Yellowe BE, Dodivi-Manuel A. Pattern and management of diabetic foot
disease in a developing country. Niger J Med. 2005; 14: 272-275.
19. Falase AO, Akinkugbe OO. Diabetes mellitus. In: A compendium of clinical
medicine. 2nd edition. Ibadan, Nigeria: Spectrum Books Limited; 2000: 387-408.
20. Nyamu PN, Otieno CF, Amayo EO, McLigeyo SO. Risk Factors and Prevalence of
Diabetic foot ulcers at Kenyatta National Hospital, Nairobi. East Afr Med J 2003; 80:36-43.
21. The International Working Group on Diabetic foot. Int Consens diabetic foot 1999;
1-96.
22. Ogbera AO, Adedokun A, Fasanmade OA, Ohwovoriole AE, Ajani M. The foot at
Risk in Nigerians with Diabetes Mellitus – The Nigerian scenario. Int J Endorcrinol Metab 2005; 4:165-173.
23. Neil Baker. Risk factors for amputation and reamputation in diabetic patients. Int
Diabetes Monitor 2007;19:4.
24. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and foot care;
Time to Act. In: chapter 8,diabetic foot care in the seven DF regions. A joint publication of the IDF and the IWGDF. Brussels .2005.
25. Solagberu BA. Diabetic foot in Nigeria – a review article. Afr J Med Sci 2003 32,
111 – 118.
26. Ndububa DA, Erhabor GE. Diabetes Mellitus in Nigerian Patients: a six-year review
of hospital admissions. Nig Med J 1996; 3: 134 – 138.
cvi
27. Bartus CI, Margolis DI. Reducing the incidence of foot ulceration and amputation
in diabetes. CurrDiab Rep. 2004; 4: 413-418.
28. Bouter KP, Storm AJ, de Grost RR, Uitslager R, Erkelena DW, Diepersloot RJ. The
diabetic foot in Dutch Hospitals: epidemiological feature and clinical outcome. Eur J Med.
1993; 2: 215-218.
29. Ogbera AO, Fasanmade O, Ohwovoriole AE, Adediran O. An assessment of the
disease burden of foot ulcers in patients with diabetes mellitus attending teaching hospital in Lagos, Nigeria. Int J Low Extrem Wounds. 2006; 5: 244-249.
30. Unachukwu C, Babatunde S, Ihekwaba AE. Diabetes, hand and/or foot ulcers. a
cross-sectional hospital-based study in Port-Harcourt, Nigeria. Diabetes Res ClinPract.
2007; 75: 148-152.
31. Fard AS, Esmaeizadeh M, Larijani B. Assessment and treatment of diabetic foot
ulcer. Int J ClinPract. 2007; 61:1931-1938.
32. Solagberu BA. The scope of amputation in a Nigerian teaching hospital. Afr J Med
Sci 2001; 30: 225 – 7.
33. Boulton AJM. The pathway to ulceration: Aetiopathogenesis. In: The foot in
diabetes. Boulton AJM. Connor H. Cavanagh P.R. (Eds), 3rd edition. John Wiley and Sons Ltd (Publishers); 2000: 19 – 31.
34. Greene D.A., Feldman E.L, Stevens M.J. et al. Diabetic Neuropathy. In: Pork D. &
Sherwn R (Eds). Diabetes Mellitus. East Norwalk, CT: Appleton & Lange (Publishers);
1997: 1009.
35. Boulton AJM, Gries FA, Jervell JA: Guidelines for the diagnosis and out-patient
management of diabetic peripheral neuropathy. Diabetic Med 1998, 15:508-514.
36. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and foot care;
Time to Act. Brussels: A joint publication of the IDF and the IWGDF; 2005, 22-27
37. Andrew J.M. Boulton, FRCP, Arthur I. Vinik, MD, Joseph C. Arezzo PHD et al.
Diabetic Neuropathies: A statement by the American Diabetes Association. Diabetes care 2005, 28: 4.
38. Warren Clayton, Jr., Tom A. Elasy. American Diabetes Association. Clinical
Diabetes. A review of pathophysiology, classification and treatment of foot ulcers in diabetic patients. Clinical Diabetes 2009, 27, 252-258.
39. Peripheral Vascular disease – Wikipedia, The free encyclopedia. Accessed on line
October, 2010.
cvii
Peripheral Arterial Disease at Merck Manual of Diagnosis and Therapy. Professional Edition, Retrieved on August 9, 2010.
40. Shammas NW (2007). “Epidemiology, Classification and modifiable risk factors of
peripheral arterial disease”. Vasc Health Risk Manag 3 (2): 229 – 34.
doi:10.2147/vhrm.2007.3.2.229. PMID 17580733.
41. Selvin E, Wattanakit K, Steffes MW, Coresh J, Sharralt AR. “HbA1c and peripheral
arterial disease in diabetes: the Atherosclerosis Risk in Communities Study”. Diabetes care 2006: 29(4): 877-82. doi:10.2337/diacare. 29.04.06. dc 05 – 2018 PMID 16567831.
42. International Consensus on the Diabetic foot & practical Guidelines on the
Management and prevention of the Diabetic foot. In: Peripheral artery disease html (1 van 9) 8-5-2007 20:43:53.
43. Fowkes FG, Housley E, Riemersma RA, et al. Smoking, Lipids, glucose intolerance,
and blood pressure as risk factors for peripheral atherosclerosis compared with ischaemic heart disease in Edingburg Artery Study. Am J Epidemiol. 1992;135:331 – 340,
44. Peripheral artery disease – Wikipedia, the free encyclopedia.
http://en.wikipedia.org. Accessed on line Jan 2008.
45. McGee SR, Boyko EJ. Physical examination and chronic lower extremity ischaemia.
A critical review. Arch Intern Med 1988; 158:1357 – 64.
46. Fontaine R, Kim M, Kieny R (1954) “Die ChirugischeBehandlung der
peripherenDurchblutungstörungen (surgical treatment of peripheral circulation disorders)” (In German). Helvetica ChirurgicaActa 21 (5/6): 499-533. PMD 14366554.
47. TASC II Guidelines
Norgren L, Hiatt WR, Dormandy JA, et al; TASC II Working Group (2007). Inter-society consensus for the management of peripheral Arterial Disease (TASC II)’’ Eur J Vasc Endovasc surg. 33 (suppl 1) :S1-75. Doi : 1016/J. ejvs. 2006. 09.024. PMID 17140820 Norgren L, Hiatt WR, Dormandy JA, TASC II Working Group, et al (2007) inter-society consensus for the management of peripheral Arterial Disease(TASC II). J vasc surg. 45(
suppl S) : S5-67. doi : 10.1016/J. JVS. 2006.12.037 PMID 17223489.
Norgren L, Hiatt WR, Dormandy JA, et al; TASC II Working Group (2007). inter-society consensus for the management of peripheral Arterial Disease” Int-Angiol. 26(2): 81-157 PMID 17489079.
cviii
48. Kumar S, Ashe HA, Parnell LN, Fernando DJ, Tsiqos C, Young RJ, Ward JD, et al.
The prevalence of foot ulceration and its correlates in Type 2 Diabetic patients: a population-based study. Diabet Med. 1994; 11(5): 480-484.
49. Walters DA, Gatlings W, Mullee MA, Hill RD. The Prevalence, detection and
epidemiological correlates of peripheral vascular disease: A comparism of Diabetic and non-diabetic subjects in an English community. Diabetic Med 1992; 9: 706 – 709.
50. Weitz JI, Byrne J, Clagett GP, et al. Diagnosis and treatment of chronic arterial
insufficiency of the lower extremities: a critical review. Circulation 1996; 94(11): 3026-3049.
51. Zinebel Pellerito. Arterial testing of the lower limb. In: chapter 12. Introduction to
vascular ultrasound. Elsevier (publisher), 2005.
52. The Diabetes Control and Complications Trial Research Group. The effect of
intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977 – 986.
53. Reichard P, Berglund B, Britz A, Nilsson BY et al. Intensified conventional insulin
treatment retards the microvascular complications of IDDM. The Stockholm Diabetes Intervention Study (SDIS) after 5 years. J. Intern. Med. 1991; 230: 101 – 108.
54. Ohkuboy, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the
progression of microvascular complications Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res ClinPract 1995;
28: 103 – 117.
55. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control
with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837 – 853.
56. Armstrong DG, Lavery LA. Diabetic foot ulcers: prevention, Diagnosis and
Classification. American family physician.Vol. 57,No. 6, 1998.
57. Miller T, Clark AS, and Stults B. Managing and preventing Diabetic foot ulcers.
Emergency Medicine 2004; 14-23. At http://www.emedmag.com.
58. Reiber GE, Vileikyte L, Boyko EJ, et al. causal pathway for incident for lower
extremity ulcers in patients with diabetes from two settings. Diabetes care 1999; 22: 157 - 162.
59. Venugopal H, Balder S. Diabetes amputations: A critical event analysis. The
Diabetic foot Journal Vol.10, No.1, 2007.
60. Ogbera AO. Foot ulceration in Nigerian diabetic patients: a study of risk factors.
DiabInt, 2007: 15-17.
cix
61. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and foot care;
Time to Act. Brussels: A joint publication of the IDF and the IWGDF; 2005.
62. Ward JD. The diabetic leg. Diabetologia 1982; 22: 141 – 7.
63. Akanji AO, Adetuyibi A. The pattern of presentation of foot lesions in Nigerian
diabetic patients. W Afr J Med 1990; 9: 1 – 5.
64. Onuba O, Udoidiok E. The scope of amputations in the developing countries
postgrad Doctor Afr 1989; 11: 118-121.
65. Adeleye JO. Diabetic foot disease: the perspective of a Nigerian tertiary health
center. PractDiabInt 2005; 22: 6. 211 – 214.
66. Oyibo SO, Jude EB, Tarawneh I, et al. A comparison of Two Diabetic Foot Ulcer
Classification Systems. Diabetes care 2001;24(1).
67. International Working Group on the Diabetic Foot. International consensus on the
Diabetic foot & practical Guidelines on the management and prevention of the Diabetic foot. In: PEDIS classification. Html(1 van 9) 8 – 5 – 2007 20: 43: 53, Amsterdam 2007.
68. Van Acker K, De Block C, Abrams P, et al. The choice of Diabetic foot ulcer
classification in Relation to the Final Outcome. Wounds 2002; 14, (1): 16-25.
69. Wagner FW, O’Neal LW. Algorithms of diabetic foot care. In: Levin ME, O’Neal LW
(eds). The Diabetic Foot. 2ndedn. St. Louis: Mosby yearbook. 1983. Pp. 291–302.
Copyright Elsevier, reproduced with permission.
70.
http/www.fpnotebook.com/legacy/surgery/exam/unvrstyOfTxsDbtcWndclsfctn.htm/2014.
71. International Working Group on the Diabetic Foot. International consensus on the
diabetic foot & practical Guidelines on the management and prevention of the Diabetic foot. Amsterdam 2007.
72. National Institute for Clinical Excellence. Clinical guideline 10; type 2 diabetes.
Prevention and management of foot problems. National Institute for Clinical Excellence 2004 (www.NICE.Org.uk/CGO10NICEguideline).
73. ADA. Summary of revisions for the 2006 clinical practice recommendations.
Diabetes care 2006; 29, (1).
74. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and foot care;
Time to Act. In: Chapter 7, organization. A joint publication of IDF and the IWGDF.
Brussels, 2005.
cx
75. Pedrosa HC, Leme LAP, Novaes C, et al. The diabetic foot in South America:
progresses with the Brazilian save the diabetic foot project. IntDiab Monitor 2004; 16: 17 – 23.
76. Bakker K, Foster AVM, Van Houtum WH, Riley P, eds. Diabetes and Foot care:
Time to Act. In: Chapter 3, Diagnosis and Treatment. A joint publication of the IDF and the IWGDF. Brussels, 2005.
77. Araoye MO. Sample size determination. In: Margaret OA (eds). Research
Methodology with statistics for health and social workers. Nathadex publishers Ilorin 2004: 115–121.
78. Young MJ, Boulton AJM, Macleod AF, Williams DRR, Sonsken PH. A multicentre
study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150 – 154.
79. Registrar General of Great Britain Classification. David Blane. Inequality of Social
Class. In:Patric DL, Scambler G. editors. Sociology as applied to medicine. London Philadelphia, Toronto. BailliereTindall 1982: 114-124.
80. WHO STEPS Surveillance. Part 3: Training and Practical Guides: Section 4: Guide
to physical measurements (steps 2). Geneva, WHO
81. WHO Technical report series 854. Physical status: The use and interpretation of
anthropometry. Geneva: WHO; 1995.
82. Sacks DB. Carbohydrate. In: Burtis CA, Ashwood ER, (eds). Tietz fundamental of
clinical chemistry. 5thed. New York: WB Saunders Company; 2001: 444 – 8.
83. Friedwald WT, Levy RI, Fredreckson DS. Estimation of the Concentration of
Low-density Lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge.
Clin Chem. 1972; 18:499 – 502.
84. 1Leese GP, Reid F, Green V, Mc Alpine R, Cunningham S, Emslie – Smith AM, et
al. Stratification of Foot ulcer risk in patients with diabetes: a population-based study. Int j clinpract 2006; 60: 541-545.
85. 1Crawford F, Inksler M, Kleijnen J, Fahey T. Predicting Foot ulcers in patients with
diabetes: a systematic review and meta-analysis. Qj- Med 2007; 100: 65-86.
86. Ogunlade SO, Alonge TO, Omololu AB, Gana JY, Salawu SA. Major limb
amputation in Ibadan. Afr J Med Sci. 2002; 31: 333-336.
cxi
87. Ikem RT, Kolawole BA, Ikem IC. The prevalence, presentation and outcome of
diabetic foot lesions in a Nigerian teaching hospital. Trop Doctor, 2002; 32:226-227.
88. Solagberu BA, Kuranga SA. Morbidity and mortality from diabetic foot post grad
Doct Afr Vol 24, No 1.
89. Akanji AO, Bella AF, Agbedana EO, Osotimehin BO and Adetuyibi A. risk factors for the development of foot lesions in Nigerian patients with diabetes mellitus. East Afr Med J. 1988; 9: 602-608.
90. Jude EB, Oyibo SO, Chalmer N, Boulton AJM. Peripheral Artery Disease in
Diabetics and non-Diabetics. A comparison of severity and outcome. Diabetes care 2001;24: 1433-1437.
91. A O Ogbera, O Adeleye, B Solegberu et al. (2015) screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in Nigerian teaching hospital. Available
http://bmcresnotes. biomedcentral.com/articles/10.1186/513104-015-1423-2.
92. Ramachandran A. Specific problems of the diabetic foot in developing countries.
Diabetes Metab Res Rev 2004; 20(Suppl): S19 – S22.
93. Dormandy J, Heeck L, Vigs: The natural history of claudication: risk to life and
limb: seminVascSurg 1999;12: 123-137.
94. Prompers L, Piagessi A, Jirkovska A et al., High prevalence of ischaemia, infection
and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale Study. Diabetologia 2007; 50: 18-25.
95. Kumar S, Fernado DJ, Veves A et al. Semmes-Weinstein Monofilaments: a simple,
effective and inexpensive screening device for identifying diabetic patients at risk of foot ulceration. Accessed online at http://www.ncbi.nlm.nih/gov/entrez (July, 2004).
96. Hasnain S Sheikh NH. Knowledge and practices regarding foot care in diabetic
patients visiting diabetic clinic in Jinnah Hospital, Lahore. J Pak Med Assoc. 2009; 59:
687-90. (Pubmed).
97. Viswanathan V, Shobhana R, Snehalatha C, Seena R, Ramachandran A. Need for
education on foot care in diabetic patients in India. J Assoc Physicians India 1999; 47:
1083-5. (Pubmed).
cxii
98. Desalu OO, Salawu FK, Jimoh AK, Adekoya AO, Busari OA, Olakoba AB. Diabetic
foot care: self reported knowledge and practice among patients attending three tertiary hospital in Nigeria. Ghana Med J. 2011; 45: 60-5 (PMCfreearticle) (Pubmed).
99. Khamseh ME, Vatankhah N, Baradaran HR. Knowledge and practice of foot care in
Iranian people with type 2 diabetes. Int Wound J. 2007; 4: 298-302. (Pubmed).
100. Fernando DJ, Hutchison A, Veves A, Gokal R, Boulton AJ. Risk factors for
non-ischaemic foot ulceration in diabetic neuropathy. Diabetes – Med 1991; 8: 223-225.
101. Markowitz JS, Gutterman EM, Magee G, Margolis DJ. Risk of amputation in
patients with diabetic foot ulcer. A claim based study. Wound Repair Regen 2006; 14:11-17.
102. Carlson T, Reed JF. A case-control study of the risk factors for toe amputation in a
diabetic population. Int J Low Extrem Wounds 2003; 2: 19-21.
103. Amos AF, MC Carthy DJ, Z.mmet O. the rising global burden of diabetes and its
complications; estimates and projections to the year 2010. Diabetes medicine 1997;
14(Supp) S1-85.
104. Mansour AA, Imran HJ. Foot abnormalities in diabetics: Prevalence and predictors
in Basrah, Iraq. Pak J Med Sci July-September 2006, 22(3), 229 – 233.
cxiii
cxiv APPENDIX A
INFORMED CONSENT FORM
PREVALENCE OF RISK FACTORS FOR FOOT ULCERATION AND ITS RELATIONSHIP TO SOME CLINICAL VARIABLES AMONG NIGERIAN PATIENTS WITH TYPE 2 DM IN JUTH
I am Dr. Rakiya Mohammed Ngoshe. I am carrying out research on the prevalence of risk factors for foot ulceration and its relationship to some clinical variables among Nigerian patients with Type 2 DM. The research will help to plan preventive strategies and public health practices that will help in decreasing morbidity from diabetic foot disease.
This research will be carried out in JUTH 1. It will be of no financial cost to you.
2. You are expected to come fasting, overnight.
3. Your blood sample will be taken with no side effects except for a little pain from the needle prick.
Your refusal to participate in this study at any stage will not in any way affect your regular management.
I, Dr/Mr/Mrs/Miss/Alh./Haj. having
read the above, fully accept to participate in the research.
Signature of participant Date
Or thumb print
Signature of Researcher (investigator) Date
Name of Interpreter/Signature Date
cxv
Name of Witness/Signature Date
APPENDIX B QUESTIONNAIRE
PREVALENCE OF RISK FACTORS FOR FOOT ULCERATION AND ITS RELATIONSHIP TO SOME CLINICAL VARIABLES AMONG NIGERIAN PATIENTS WITH TYPE 2 DM IN JUTH
Serial number Date
1. Sociodemographic Data 3) Initials
4) Hospital Number 5) Age (years)
6) Sex (Tick) Male ( ) Female ( ) 7) Social class: (Tick)
1.
2.
3. 4.
5.
8) Marital status – single ( ) Divorced ( ) Married ( ) Widowed ( ) 9) Education level – none ( ) Informal ( )
Primary ( ) Secondary ( ) Tertiary ( ) Postgraduate ( ) 10) Residence – Urban ( ) Rural ( )
SOCIAL HISTORY Alcohol (Tick) i. Not at all ( )
ii. Took alcohol regularly before, but has now stopped ( )
iii. Took alcohol regularly before, but now takes only occasionally ( ) iv. Takes alcohol only occasionally ( )
v. Takes alcohol regularly ( ) If patient took/takes alcohol
cxvi Duration – years/months
Quantity/Number of bottles/calabashes/day Approximate number of grams/day
Cigarette (tick)
i. Smoker. Has smoke for atleast one year ( )
ii. Ex-smoker. Stopped for at least one year after smoking regularly ( ) iii. Non-smoker. Has smoke cigarette before but regularly ( )
iv. Non-smoker. Never smoke ( )
For patient who smoke/had smoked what is:
Duration in years/months Number of sticks per day Number of pack years 2. MEDICAL HISTORY
11) Is patient hypertensive? Yes ( ) No ( ) 12) Type of diabetes
13) Duration of diabetes (years)
14) Has the patient had a previous foot ulcer?
15) If yes to above question state which foot and the site of ulcer
16) Has the patient had a previous lower limb amputation? Yes ( ) No ( )
17) IF YES TO ABOVE QUESTION STATE WHICH LIMB AND THE TYPE OF